2008
$438M
from 10 investors over 10 rounds
Biosplice Therapeutics raised $120M on April 15, 2021
Investors: Eventide Asset Management, aMoon Fund and Sands Capital Management
Biosplice Therapeutics raised $438M on August 6, 2018
Investors: Swicorp, Vickers Venture Partners and Starling International Management Limited
Biosplice Therapeutics raised $220M on September 1, 2013
Investors: Polar Light Ventures, Vickers Venture Partners and Starling International Management Limited
Biosplice Therapeutics raised undisclosed on September 1, 2012
Investors: Esas Ventures